230 related articles for article (PubMed ID: 28854900)
81. Low oxygen tension enhances endothelial fate of human pluripotent stem cells.
Kusuma S; Peijnenburg E; Patel P; Gerecht S
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):913-20. PubMed ID: 24526696
[TBL] [Abstract][Full Text] [Related]
82. Control of leucocyte differentiation from embryonic stem cells upon vasculogenesis and confrontation with tumour tissue.
Hannig M; Figulla HR; Sauer H; Wartenberg M
J Cell Mol Med; 2010 Jan; 14(1-2):303-12. PubMed ID: 20414974
[TBL] [Abstract][Full Text] [Related]
83. Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.
Wu Y; Gao J; Liu X
Cancer Cell Int; 2021 Mar; 21(1):171. PubMed ID: 33726754
[TBL] [Abstract][Full Text] [Related]
84. VE-cadherin-based matrix promoting the self-reconstruction of pro-vascularization microenvironments and endothelial differentiation of human mesenchymal stem cells.
Xie J; Li X; Zhang Y; Tang T; Chen G; Mao H; Gu Z; Yang J
J Mater Chem B; 2021 Apr; 9(15):3357-3370. PubMed ID: 33881442
[TBL] [Abstract][Full Text] [Related]
85. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Bagley RG; Rouleau C; St Martin T; Boutin P; Weber W; Ruzek M; Honma N; Nacht M; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Mol Cancer Ther; 2008 Aug; 7(8):2536-46. PubMed ID: 18723498
[TBL] [Abstract][Full Text] [Related]
86. Blood flow patterns switch VEGFR2 activity through differential S-nitrosylation and S-oxidation.
Kang DH; Kim Y; Min S; Lee SY; Chung KY; Baek IJ; Kwon K; Jo H; Kang SW
Cell Rep; 2023 Nov; 42(11):113361. PubMed ID: 37910508
[TBL] [Abstract][Full Text] [Related]
87. Potassium Dehydroandrograpolide Succinate Targets NRP1 Mediated VEGFR2/VE-Cadherin Signaling Pathway to Promote Endothelial Barrier Repair.
Wang Z; Wu X; Li J; Guo Q; Jin Z; Li H; Liang B; Hu W; Xu H; Shi L; Yang L; Wang Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834519
[TBL] [Abstract][Full Text] [Related]
88. Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice.
Vuletic I; Zhou K; Li H; Bai H; Meng X; Zhu S; Ding Y; Li J; Sun H; Ren Q
Mol Imaging Biol; 2017 Dec; 19(6):847-856. PubMed ID: 28315202
[TBL] [Abstract][Full Text] [Related]
89. Altered Calreticulin expression in human colon cancer: maintenance of Calreticulin expression is associated with mucinous differentiation.
Toquet C; Jarry A; Bou-Hanna C; Bach K; Denis MG; Mosnier JF; Laboisse CL
Oncol Rep; 2007 May; 17(5):1101-7. PubMed ID: 17390051
[TBL] [Abstract][Full Text] [Related]
90. Lacteal junction zippering protects against diet-induced obesity.
Zhang F; Zarkada G; Han J; Li J; Dubrac A; Ola R; Genet G; Boyé K; Michon P; Künzel SE; Camporez JP; Singh AK; Fong GH; Simons M; Tso P; Fernández-Hernando C; Shulman GI; Sessa WC; Eichmann A
Science; 2018 Aug; 361(6402):599-603. PubMed ID: 30093598
[TBL] [Abstract][Full Text] [Related]
91. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.
Yao K; Gietema JA; Shida S; Selvakumaran M; Fonrose X; Haas NB; Testa J; O'Dwyer PJ
Br J Cancer; 2005 Dec; 93(12):1356-63. PubMed ID: 16333244
[TBL] [Abstract][Full Text] [Related]
92. In Development-A New Paradigm for Understanding Vascular Disease.
Flavahan NA
J Cardiovasc Pharmacol; 2017 May; 69(5):248-263. PubMed ID: 28328747
[TBL] [Abstract][Full Text] [Related]
93. The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation.
Martinez JO; Evangelopoulos M; Karun V; Shegog E; Wang JA; Boada C; Liu X; Ferrari M; Tasciotti E
Biomaterials; 2014 Dec; 35(37):9824-9832. PubMed ID: 25176066
[TBL] [Abstract][Full Text] [Related]
94. Endothelial cells instruct liver specification of embryonic stem cell-derived endoderm through endothelial VEGFR2 signaling and endoderm epigenetic modifications.
Han S; Tan C; Ding J; Wang J; Ma'ayan A; Gouon-Evans V
Stem Cell Res; 2018 Jul; 30():163-170. PubMed ID: 29936335
[TBL] [Abstract][Full Text] [Related]
95. The clinical significance and biological function of tropomyosin 4 in colon cancer.
Yang R; Zheng G; Ren D; Chen C; Zeng C; Lu W; Li H
Biomed Pharmacother; 2018 May; 101():1-7. PubMed ID: 29455030
[TBL] [Abstract][Full Text] [Related]
96. Mechanotransduction: VE-cadherin lets it flow.
Du Toit A
Nat Rev Mol Cell Biol; 2015 May; 16(5):268. PubMed ID: 25907610
[No Abstract] [Full Text] [Related]
97. VE-cadherin in perineuriomas.
Ali A; Stoddard CA; Smith ME
Histopathology; 2003 Jun; 42(6):620-1. PubMed ID: 12786903
[No Abstract] [Full Text] [Related]
98. Suprabasin as a novel tumor endothelial cell marker.
Alam MT; Nagao-Kitamoto H; Ohga N; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Taketomi A; Shindoh M; Hida Y; Hida K
Cancer Sci; 2014 Dec; 105(12):1533-40. PubMed ID: 25283635
[TBL] [Abstract][Full Text] [Related]
99. Differentiation and expansion of endothelial cells requires pre-optimization of KDR+ expression kinetics.
Jahan B; McCloskey KE
Stem Cell Res; 2020 Jan; 42():101685. PubMed ID: 31896485
[TBL] [Abstract][Full Text] [Related]
100. RF-assisted gadofullerene nanoparticles induces rapid tumor vascular disruption by down-expression of tumor vascular endothelial cadherin.
Li X; Zhen M; Deng R; Yu T; Li J; Zhang Y; Zou T; Zhou Y; Lu Z; Guan M; Xu H; Shu C; Wang C
Biomaterials; 2018 May; 163():142-153. PubMed ID: 29459323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
